Purpose: The objective of this study was to determine the impact of a pharmacy-managed pharmacokinetic dosing program on appropriate dosing of famotidine, enoxaparin, and ketorolac.
Methods: A large community teaching hospital implemented a pharmacy-managed pharmacokinetic dosing program for famotidine, enoxaparin, and ketorolac. Subjects were included if they received famotidine and had a creatinine clearance (CrCl) of <50 mL/min; received therapeutic enoxaparin and had a CrCl of <30 mL/min; or received ketorolac and had a CrCl <30 mL/min, age > 65 years or weight <50 kg.
Results: One hundred and forty-six patients were included in the preimplementation group (famotidine [n = 50], enoxaparin [n = 46], and ketorolac [n = 50]) and 143 patients were included in the postimplementation group (famotidine [n = 50], enoxaparin [n = 43], and ketorolac [n = 50]). In all, 66% of patients were dosed appropriately in the preimplementation group (famotidine 28%, enoxaparin 85%, and ketorolac 86%) compared to 94% in the postimplementation group (famotidine 92%, enoxaparin 95%, and ketorolac 94%), P < .001.
Conclusion: Implementation of a pharmacy-managed pharmacokinetic dosing program significantly improved appropriate dosing of famotidine, enoxaparin, and ketorolac. These findings could justify expansion of pharmacist autonomy through institution-approved, pharmacy-managed programs for other medications to improve appropriate dosing. Analyses specifically evaluating patient-oriented or financial outcomes may provide additional support for expansion.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0897190014544825 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
J Manag Care Spec Pharm
August 2019
6The Permanente Medical Group, Oakland, California.
Article Synopsis
- In elderly patients, medications can lead to adverse effects, prompting the need for deprescribing, which involves carefully reducing or stopping medications that may be harmful or unnecessary.
- The study evaluated the impact of a pharmacist-managed deprescribing program for antidiabetic medications on the risk of hypoglycemia and other health outcomes, comparing it to standard care in an integrated health care system.
- Results showed that patients in the deprescribing program experienced similar demographics and clinical outcomes compared to those receiving usual care, suggesting a potential benefit in managing diabetes medications for older adults.
Evaluation of a Pharmacy-Managed Pharmacokinetic Dosing Program.
J Pharm Pract
December 2015
Mercy Hospital St Louis, Department of Pharmacy Services, Saint Louis, MO, USA.
Purpose: The objective of this study was to determine the impact of a pharmacy-managed pharmacokinetic dosing program on appropriate dosing of famotidine, enoxaparin, and ketorolac.
Methods: A large community teaching hospital implemented a pharmacy-managed pharmacokinetic dosing program for famotidine, enoxaparin, and ketorolac. Subjects were included if they received famotidine and had a creatinine clearance (CrCl) of <50 mL/min; received therapeutic enoxaparin and had a CrCl of <30 mL/min; or received ketorolac and had a CrCl <30 mL/min, age > 65 years or weight <50 kg.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!